Graham Capital Management’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$226K Buy
+21,694
New +$242K ﹤0.01% 996
2026
Q1
– Sell
-29,992
Closed -$299K – 1132
2025
Q4
$299K Buy
29,992
+8,316
+38% +$79.4K 0.01% 856
2025
Q3
$194K Buy
+21,676
New +$201K ﹤0.01% 1059
2024
Q1
– Sell
-98,311
Closed -$717K – 1039
2023
Q4
$717K Buy
98,311
+69,169
+237% +$545K 0.02% 479
2023
Q3
$265K Buy
+29,142
New +$349K 0.01% 763
2022
Q2
– Sell
-59,005
Closed -$945K – 980
2022
Q1
$945K Buy
+59,005
New +$1.06M 0.03% 324

Other funds holding AHCO

Graham Capital Management's AHCO Position: Q2 2026 in Review

Graham Capital Management opened a new position in AdaptHealth (AHCO) in Q2 2026: 21,694 shares worth $226K. The stake represents ﹤0.01% of the portfolio and ranks #996 among its holdings. This is a return to the name: Graham Capital Management previously reported a position in AHCO as recently as Q4 2025.

Graham Capital Management first reported a position in AHCO in Q1 2022 and has held it in 6 quarters since. The position peaked at $945K in Q1 2022. 239 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Graham Capital Management held 21,694 shares of AdaptHealth worth $226K as of Q2 2026.
  • AdaptHealth was a new Graham Capital Management position in Q2 2026.
  • AdaptHealth made up ﹤0.01% of Graham Capital Management's portfolio in Q2 2026, its #996 holding.
  • Graham Capital Management first reported a position in AdaptHealth in Q1 2022 and has held it in 6 quarters since.
  • Graham Capital Management's AdaptHealth position peaked at $945K in Q1 2022.
  • 239 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.